Z-0352-2024 Class II Ongoing

Recalled by Roche Diagnostics Operations, Inc. — Indianapolis, IN

FDA device recall Z-0352-2024 was initiated by Roche Diagnostics Operations, Inc. on Oct 3, 2023 and is designated Class II. Reason for recall: Elevated results were detected with Li-heparin plasma samples when compared to citrated plasma samples. The recall status is ongoing. Affected quantity: 5,263 kits.

Recall details

Product Type
Devices
Report Date
Nov 29, 2023
Initiation Date
Oct 3, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
5,263 kits

Product description

Tina-quant D-Dimer Test System, Fibrinogen/Fibrin Degradation Products Assay, Material Numbers 03001245322 - (cobas c 311, 501 and 502; INTEGRA 400 plus), 08105618190 - (cobas c 303 and 503)

Reason for recall

Elevated results were detected with Li-heparin plasma samples when compared to citrated plasma samples.

Distribution pattern

US Nationwide distribution.

Code information

All Lots Affected. UDI: 04015630914593 - (cobas c 311, 501 and 502; INTEGRA 400 plus) UDI: 07613336133651 - (cobas c 303 and 503)

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0352-2024
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0352-2024. Report a data issue: hello@regdatalab.com.